Intuitive Surgical stays a Buy despite slower growth and price pressures, backed by strong cash flow and market lead.

Intuitive Surgical remains a Buy due to its strong recurring revenue, robust cash generation, and leading position in robotic surgery. Recent share price declines reflect slower procedure growth and affordability challenges, but the company’s installed base, upgrade cycles, and new technology adoption support long-term growth. Margins are expected to peak this year, helped by programs that reduce system costs and raise competitive barriers. The $689.75 price target is based on premium valuation multiples, strong cash flow, and low debt, with risks including affordability and competition.

Intuitive Surgical shares are currently priced at USD 395.17 on Pluang, down 1.51% in the last day. The stock shows strong investor interest with 96% of order activity as buys and a market cap of $141.75 billion as of Oct 03, 2026 00:31 WIB.